The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 49 (3) , 287-294
- https://doi.org/10.1016/0047-6374(89)90079-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: Trimethadione and antipyrine metabolism as an indicator.Journal of Pharmacobio-Dynamics, 1985
- A decrease in the capacity of hepatocytes isolated from aged male BN/BiRij rats to metabolize digitoxinBiochemical Pharmacology, 1984
- Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in ratsXenobiotica, 1983
- Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivoXenobiotica, 1983
- Interindividual Variations in Drug DispositionClinical Pharmacokinetics, 1983
- Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrinein vitroby microsomal fractions of rat liverXenobiotica, 1982
- Antipyrine metabolism in the rat by three hepatic monooxygenasesLife Sciences, 1980
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- The Effect of Spironolactone on Antipyrine Metabolism in ManPharmacology, 1973